Clinical Trial Update: A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma [Phase 2]

View source ↗

Summary

The Phase 2 trial of ONO-6950 in patients with asthma, comparing placebo and active control after allergen challenge, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ONO-6950

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Asthma | Phase 2 | Status: COMPLETED